Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Gains from Investment Securities: 2009-2024

Historic Gains from Investment Securities for Select Medical Holdings (SEM) over the last 16 years, with FY2024 value amounting to $133.2 million.

  • Select Medical Holdings' Gains from Investment Securities fell 7200.14% to $11.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.0 million, marking a year-over-year decrease of 4528.55%. This contributed to the annual value of $133.2 million for FY2024, which is 5047.68% up from last year.
  • Per Select Medical Holdings' latest filing, its Gains from Investment Securities stood at $133.2 million for FY2024, which was up 5047.68% from $88.5 million recorded in FY2023.
  • Select Medical Holdings' 5-year Gains from Investment Securities high stood at $181.2 million for FY2021, and its period low was $32.3 million during FY2022.
  • Over the past 5 years, Select Medical Holdings' median Gains from Investment Securities value was $108.9 million (recorded in 2020), while the average stood at $108.8 million.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first tumbled by 8217.83% in 2022, then skyrocketed by 17410.96% in 2023.
  • Over the past 5 years, Select Medical Holdings' Gains from Investment Securities (Annual) stood at $108.9 million in 2020, then skyrocketed by 66.39% to $181.2 million in 2021, then plummeted by 82.18% to $32.3 million in 2022, then surged by 174.11% to $88.5 million in 2023, then soared by 50.48% to $133.2 million in 2024.
  • Its last three reported values are $133.2 million in FY2024, $88.5 million for FY2023, and $32.3 million during FY2022.